G Medical Innovations Holdings Ltd(OTC:GMVDF)

G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. It operates through the following segments: Products, Patient Services, and Covid-19 Testing, and Kits. The Products segment includes the development, manufacture, and marketing of trans-telephonic and wireless diagnostic equipment for the medical industry and consumer market. The Patient Services segment focuses on cardiac monitoring services of MCT, Patch, Event, Extended Holter, and Pacemaker. The Covid -19 Testing segment covers three kinds of diagnostic tests which are Rapid Antigen + A/B Flu Combo test, PCR test, and Antibody test. The Kits segment engages in direct-To-Customer health testing kits health issues ranging from food sensitivity, indoor/outdoor allergies, HPV, thyroid functioning, testosterone levels, and the hemoglobin A1C test. The company was founded in August 2014 and is headquartered in George Town, Cayman Islands.